REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 172 filers reported holding REGENXBIO INC in Q1 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $123,000 | +17.1% | 7,461 | +43.0% | 0.00% | – |
| Q2 2023 | $105,000 | +47.9% | 5,219 | +36.8% | 0.00% | – |
| Q1 2023 | $71,000 | -52.3% | 3,814 | -41.3% | 0.00% | – |
| Q4 2022 | $149,000 | +302.7% | 6,496 | +365.0% | 0.00% | – |
| Q3 2022 | $37,000 | +208.3% | 1,397 | +189.8% | 0.00% | – |
| Q2 2022 | $12,000 | -86.8% | 482 | -82.5% | 0.00% | – |
| Q1 2022 | $91,000 | -64.9% | 2,747 | -65.2% | 0.00% | – |
| Q4 2021 | $259,000 | +57.0% | 7,900 | +100.5% | 0.00% | – |
| Q3 2021 | $165,000 | +32.0% | 3,940 | +23.0% | 0.00% | – |
| Q2 2021 | $125,000 | +62.3% | 3,203 | +42.5% | 0.00% | – |
| Q1 2021 | $77,000 | -82.1% | 2,248 | -76.2% | 0.00% | – |
| Q4 2020 | $429,000 | +78.8% | 9,460 | +8.4% | 0.00% | – |
| Q3 2020 | $240,000 | -31.8% | 8,726 | -8.6% | 0.00% | – |
| Q2 2020 | $352,000 | +2.3% | 9,552 | -10.1% | 0.00% | – |
| Q1 2020 | $344,000 | +42.7% | 10,626 | +80.9% | 0.00% | – |
| Q4 2019 | $241,000 | +162.0% | 5,875 | +125.5% | 0.00% | – |
| Q3 2019 | $92,000 | -54.2% | 2,605 | -33.4% | 0.00% | – |
| Q2 2019 | $201,000 | +21.8% | 3,910 | +36.2% | 0.00% | – |
| Q1 2019 | $165,000 | +223.5% | 2,870 | +136.4% | 0.00% | – |
| Q4 2018 | $51,000 | -75.7% | 1,214 | -56.2% | 0.00% | – |
| Q3 2018 | $210,000 | +156.1% | 2,771 | +141.8% | 0.00% | – |
| Q2 2018 | $82,000 | +8100.0% | 1,146 | +2628.6% | 0.00% | – |
| Q1 2018 | $1,000 | -98.1% | 42 | -97.4% | 0.00% | – |
| Q4 2017 | $54,000 | -66.5% | 1,638 | -66.5% | 0.00% | – |
| Q3 2017 | $161,000 | +347.2% | 4,891 | +170.2% | 0.00% | – |
| Q2 2017 | $36,000 | +50.0% | 1,810 | +40.2% | 0.00% | – |
| Q1 2017 | $24,000 | -36.8% | 1,291 | -36.7% | 0.00% | – |
| Q4 2016 | $38,000 | +245.5% | 2,039 | +154.9% | 0.00% | – |
| Q3 2016 | $11,000 | +83.3% | 800 | 0.0% | 0.00% | – |
| Q2 2016 | $6,000 | -50.0% | 800 | -27.3% | 0.00% | – |
| Q1 2016 | $12,000 | -33.3% | 1,100 | 0.0% | 0.00% | – |
| Q4 2015 | $18,000 | 0.0% | 1,100 | +37.5% | 0.00% | – |
| Q3 2015 | $18,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |